Prot #ALN-TTR02-006: A Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Patisiran in Patients with Familial Amyloidotic Polyneuropathy who have Completed a Prior Clinical Study with Patisiran

Project: Research project

Project Details

StatusActive
Effective start/end date2/18/162/18/22

Funding

  • Medpace, Inc. (ALN-TTR02-006)
  • Alnylam Pharmaceuticals, Inc. (ALN-TTR02-006)